Dihydrotachysterol
Jump to navigation
Jump to search
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a682335 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
Chemical and physical data | |
Formula | C28H46O |
Molar mass | 398.675 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.
![]() | この記事は、クリエイティブ・コモンズ・表示・継承ライセンス3.0のもとで公表されたウィキペディアの項目Dihydrotachysterol(29 January 2023編集記事参照)を素材として二次利用しています。 Item:Q22022 ![]() |